Inventor · disambiguated record
Alexander V. Mayweg
Also filed as: MAYWEG ALEXANDER · MAYWEG ALEXANDER V
43 granted patents·6 pending applications·130 citations·filing 2003–2021
97Inventor score
Files withHOFFMANN LA ROCHE31BANNER DAVID4ACKERMANN JEAN3ANDREINI MATTEO3BLACK DIAMOND THERAPEUTICS INC3
Top patents by PatentIndex Score
49 records- 0194US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0289US10035804B2Spirodiamine derivatives as aldosterone synthase inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Jul 31, 2018·10 cites·20 claims
- 0387US7964594B1Amino oxazine derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Jun 21, 2011·12 cites·30 claims
- 0486US9695151B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 4, 2017·6 cites·24 claims
- 0586US9695152B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 4, 2017·6 cites·23 claims
- 0685US11034672B1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·2 cites·29 claims
- 0784US8389513B22-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amidesBANNER DAVID·Filed 2010·Granted Mar 5, 2013·9 cites·31 claims
- 0883US8129423B2Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitorsACKERMANN JEAN·Filed 2007·Granted Mar 6, 2012·6 cites·11 claims
- 0983US7678795B2Pyridazines as 11b-HSD1 inhibitorsHOFFMANN LA ROCHE·Filed 2006·Granted Mar 16, 2010·6 cites·17 claims
- 1081US9505742B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Nov 29, 2016·4 cites·24 claims
- 1180US8461160B2DihydropyrimidinonesBANNER DAVID·Filed 2010·Granted Jun 11, 2013·3 cites·20 claims
- 1278US7294644B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2003·Granted Nov 13, 2007·10 cites·26 claims
- 1377US9260408B2Dihydroquinoline-2-one derivativesAEBI JOHANNES·Filed 2012·Granted Feb 16, 2016·4 cites·43 claims
- 1476US8501940B2Tetrahydrocinnoline derivativesACKERMANN JEAN·Filed 2009·Granted Aug 6, 2013·2 cites·12 claims
- 1576US7547697B2Alkyl-pyridazine derivatives as 11b-HSD1 inhibitorsHOFFMANN LA ROCHE·Filed 2007·Granted Jun 16, 2009·2 cites·19 claims
- 1676US7528159B25-aryl pyridines as 11-beta inhibitors for the treatment of diabetesHOFFMANN LA ROCHE·Filed 2005·Granted May 5, 2009·2 cites·16 claims
- 1774US11633488B2Modified IL-2 polypeptides and uses thereofBRIGHT PEAK THERAPEUTICS AG·Filed 2021·Granted Apr 25, 2023·1 cites·20 claims
- 1873US9187429B2Phenyl-tetrahydroisoquinoline derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Nov 17, 2015·2 cites·42 claims
- 1973US8815881B21,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsBANNER DAVID·Filed 2011·Granted Aug 26, 2014·1 cites·14 claims
- 2073US8673894B22,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compoundsBANNER DAVID·Filed 2011·Granted Mar 18, 2014·2 cites·17 claims
- 2173US7579369B2CB 1 receptor inverse agonistsHOFFMANN LA ROCHE·Filed 2007·Granted Aug 25, 2009·1 cites·26 claims
- 2271US7507733B211b-HSD1 inhibitors for the treatment of diabetesHOFFMANN LA ROCHE·Filed 2005·Granted Mar 24, 2009·1 cites·18 claims
- 2371US7482341B2PyridinesHOFFMANN LA ROCHE·Filed 2005·Granted Jan 27, 2009·1 cites·16 claims
- 2467US9353081B2Bicyclic dihydroquinoline-2-one derivativesAEBI JOHANNES·Filed 2012·Granted May 31, 2016·1 cites·21 claims
- 2566US8748418B21,4-oxazepines as BACE1 and/or BACE2 inhibitorsGABELLIERI EMANUELE·Filed 2012·Granted Jun 10, 2014·2 cites·28 claims
- 2660US2014336208A11,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2758US2022363666A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2855US8211913B25-aryl pyridines as 11-beta inhibitors for the treatment of diabetesAMREIN KURT·Filed 2009·Granted Jul 3, 2012·0 cites·21 claims
- 2953US8124636B2Imidazolidinone derivatives as 11B-HSD1 inhibitorsACKERMANN JEAN·Filed 2009·Granted Feb 28, 2012·0 cites·11 claims
- 3052US2013196984A13-amino-5-phenyl-56-dihydro-2h-[1,4]oxazinesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3151US2014045820A12,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3247US2012214806A13-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazinesANDREINI MATTEO·Filed 2012·Application pending·0 cites
- 3346US8188079B23-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazinesANDREINI MATTEO·Filed 2010·Granted May 29, 2012·0 cites·19 claims
- 3446US7652057B2Pyrazolones as 11b-HSD1 inhibitors for diabetesHOFFMANN LA ROCHE·Filed 2006·Granted Jan 26, 2010·0 cites·19 claims
- 3543US9464058B2Imidazolylketone derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Oct 11, 2016·0 cites·17 claims
- 3643US7622492B2Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenaseHOFFMANN LA ROCHE·Filed 2006·Granted Nov 24, 2009·0 cites·22 claims
- 3743US7563910B2Heterocyclic cannabinoid receptor antagonistsHOFFMANN LA ROCHE·Filed 2005·Granted Jul 21, 2009·0 cites·22 claims
- 3843US7528158B2Indazolone derivatives useful as 11b-HSD1 inhibitorsHOFFMANN LA ROCHE·Filed 2005·Granted May 5, 2009·0 cites·28 claims
- 3942US9790200B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 17, 2017·0 cites·19 claims
- 4041US9796726B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 24, 2017·0 cites·21 claims
- 4141US9796702B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 24, 2017·0 cites·20 claims
- 4241US9133158B2Bicyclic dihydroisoquinoline-1-one derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Sep 15, 2015·0 cites·56 claims
- 4341US2022041613A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4440US9790217B2Pyridinyloxy- and phenyloxy-pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 17, 2017·0 cites·20 claims
- 4538US9636338B2Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthaseHOFFMANN LA ROCHE·Filed 2016·Granted May 2, 2017·0 cites·19 claims
- 4638US9636339B2Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted May 2, 2017·0 cites·19 claims
- 4737US9593107B2Dihydroquinoline-2-one derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Mar 14, 2017·0 cites·22 claims
- 4837US9458135B2Dihydroquinoline-2-one derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Oct 4, 2016·0 cites·25 claims
- 4935US9242943B21,4 oxazines as BACE1 and/or BACE2 inhibitorsANDREINI MATTEO·Filed 2012·Granted Jan 26, 2016·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Alexander V. Mayweg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →